微创二尖瓣修复是否意味着术后疼痛更轻?
本研究对比微创手术与胸骨切开术行二尖瓣修复的术后疼痛评分及阿片类药物用量。2008至2019年间,1332例接受胸骨切开术,913例接受微创手术,倾向性评分1:1匹配后每组709例。微创组术后中位住院时间更短,前4天阿片类药物用量更低,但术后24小时内疼痛评分更高。
要点
- 微创二尖瓣修复组术后中位住院时间为3(3-4)天,胸骨切开组为5(4-5)天(P < .001)。
- 微创组前4天预测口服吗啡当量几何均值低于胸骨切开组。
- 微创组术后24小时内预测平均疼痛评分高于胸骨切开组(4.7 [4.5-4.8] vs 4.4 [4.3-4.5],视觉模拟评分0至10分)。
核心结论
- 微创二尖瓣修复与阿片类药物用量减少相关,但与术后疼痛评分降低无关。
- 可能的解释包括切口部位疼痛差异及术后疼痛预期的个体差异。
研究设计与样本
- 研究纳入2008年至2019年接受孤立性二尖瓣修复的患者,胸骨切开组1332例,微创组913例。
- 经1:1倾向性评分匹配后,每组各纳入709例患者。
- 阿片类药物用量以每住院日口服吗啡当量毫克数定量,疼痛评分取视觉模拟评分每6小时区间的最高值。
- 采用预测模型比较两组疼痛药物用量及疼痛评分。
主要发现
- 微创组术后中位住院时间为3(3-4)天,胸骨切开组为5(4-5)天(P < .001)。
- 预测口服吗啡当量几何均值显示,微创组前4天阿片类药物用量低于胸骨切开组。
- 微创组术后24小时内预测平均疼痛评分高于胸骨切开组,分别为4.7(4.5-4.8)与4.4(4.3-4.5)(视觉模拟评分0至10分)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rapid recovery after minimally invasive mitral valve (MV) repair has been demonstrated in many studies, but the issue of postoperative pain has not been fully elucidated. We evaluated pain scores and medication use in patients undergoing MV repair by minimally invasive surgery (MIS) and open sternotomy (OS). METHODS: Between 2008 and 2019, 1332 patients underwent isolated MV repair by OS, and 913 underwent minimally invasive MV repair. After 1:1 propensity score matching, the study included 709 patients in each group. Opioid use was quantified as oral morphine equivalents in milligrams for each hospital day. The highest pain scores were collected from a visual analogue scale at 6-hour intervals. Predictive modeling was employed to compare pain medications and pain scores between the groups. RESULTS: The postoperative median length of stay was 3 (3-4) and 5 (4-5) days for the MIS and OS groups, respectively (P < .001). The predicted geometric mean oral morphine equivalents demonstrated lower opioid use for the MIS group compared with the OS group for the first 4 days. However, the predicted mean pain score was higher in the first 24 hours for the MIS group compared with the OS group (4.7 [4.5-4.8] vs 4.4 [4.3-4.5], respectively, on a visual analogue scale of 0 to 10). CONCLUSIONS: MV repair by MIS methods was associated with decreased opioid use but not with decreased postoperative pain scores. Possible explanations include the difference in incision site pain and subjective differences in postoperative pain expectations.
引用
- Jahanian S, Arghami A, Wittwer ED, et al. Does Minimally Invasive Mitral Valve Repair Mean Less Postoperative Pain? Ann Thorac Surg. 2022. PMID: 36395877. doi:10.1016/j.athoracsur.2022.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。